©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Respirol. Mar 28, 2015; 5(1): 34-39
Published online Mar 28, 2015. doi: 10.5320/wjr.v5.i1.34
Published online Mar 28, 2015. doi: 10.5320/wjr.v5.i1.34
New therapies for chronic obstructive pulmonary disease, lung regeneration
Masaki Fujita, Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan
Author contributions: Fujita M solely contributed to this paper.
Conflict-of-interest: None.
Correspondence to: Masaki Fujita, MD, PhD, Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonanku, Fukuoka 814-0180, Japan. mfujita@fukuoka-u.ac.jp
Telephone: +81-92-8011011 Fax: +81-92-8656220
Received: September 20, 2014
Peer-review started: September 20, 2014
First decision: November 27, 2014
Revised: December 15, 2014
Accepted: January 15, 2015
Article in press: January 17, 2015
Published online: March 28, 2015
Processing time: 184 Days and 19.1 Hours
Peer-review started: September 20, 2014
First decision: November 27, 2014
Revised: December 15, 2014
Accepted: January 15, 2015
Article in press: January 17, 2015
Published online: March 28, 2015
Processing time: 184 Days and 19.1 Hours
Core Tip
Core tip: There is currently no proven clinically effective treatment for achieving recovery from established emphysema. At present, regeneration is the only hope for a cure in patients with chronic obstructive pulmonary disease (COPD). In this article, we review current treatments for COPD, focusing particularly on recent advances in lung regeneration. This article aims to provide valuable information for developing new therapies for COPD.